KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Receivables - Other (2017 - 2024)

Historic Receivables - Other for Novartis Ag (NVS) over the last 9 years, with Q4 2025 value amounting to $1.1 billion.

  • Novartis Ag's Receivables - Other rose 401.09% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 401.09%. This contributed to the annual value of $1.1 billion for FY2025, which is 401.09% up from last year.
  • As of Q4 2025, Novartis Ag's Receivables - Other stood at $1.1 billion, which was up 401.09% from $1.1 billion recorded in Q4 2024.
  • In the past 5 years, Novartis Ag's Receivables - Other ranged from a high of $1.3 billion in Q4 2023 and a low of $793.0 million during Q4 2021
  • Over the past 5 years, Novartis Ag's median Receivables - Other value was $1.1 billion (recorded in 2024), while the average stood at $1.0 billion.
  • Per our database at Business Quant, Novartis Ag's Receivables - Other crashed by 1765.32% in 2021 and then skyrocketed by 3068.89% in 2023.
  • Quarter analysis of 5 years shows Novartis Ag's Receivables - Other stood at $793.0 million in 2021, then increased by 20.81% to $958.0 million in 2022, then soared by 30.69% to $1.3 billion in 2023, then dropped by 12.38% to $1.1 billion in 2024, then rose by 4.01% to $1.1 billion in 2025.
  • Its Receivables - Other was $1.1 billion in Q4 2025, compared to $1.1 billion in Q4 2024 and $1.3 billion in Q4 2023.